Literature DB >> 2710120

Definition of the human raf amino-terminal regulatory region by deletion mutagenesis.

V P Stanton1, D W Nichols, A P Laudano, G M Cooper.   

Abstract

Activation of transforming potential of the cellular raf gene has uniformly been associated with the deletion of amino-terminal coding sequences. In order to determine whether 5' truncation alone could activate cellular raf, we constructed 21 human c-raf-1 cDNAs with variable BAL 31-generated deletions distal to a Moloney murine sarcoma virus long terminal repeat and a consensus translation initiation sequence. The deletions ranged from 136 to 1,399 nucleotides of coding sequence and shortened the 648-amino-acid raf protein by 44 to 465 amino acids. The full-length c-raf-1 cDNA was nontransforming upon transfection of NIH 3T3 cells, as were four mutants with deletions of 142 or fewer amino acids. Seven of nine mutants with deletions of 154 to 273 amino acids induced transformation with efficiencies ranging from 0.25 to 70 foci per micrograms of DNA. Mutants with deletions of 303 to 324 amino acids displayed high transforming activities (comparable with that of v-raf), with a peak activity of 2,400 foci per microgram of DNA when 305 amino acids were deleted. Deletions of greater than 383 amino acids, extending into the raf kinase domain, lacked transforming activity. Northern (RNA) blotting and immunoprecipitation assays indicated that transfected NIH cells expressed raf RNAs and proteins of the expected sizes. Thus, 5' truncation alone can activate raf transforming potential, with a sharp peak of activation around amino acid 300. Analysis of three raf genes previously detected by transfection of tumor DNAs indicated that these genes were activated by recombination in raf intron 7 and encoded fusion proteins containing amino-terminal non-raf sequences. The extend of deletion of raf sequences in these recombinant genes corresponded to BAL 31 mutants which did not display high transforming activity, suggesting that the fused non-raf coding sequences may also contribute to biological activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2710120      PMCID: PMC362641          DOI: 10.1128/mcb.9.2.639-647.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Activation of human c-raf-1 by replacing the N-terminal region with different sequences.

Authors:  T Tahira; M Ochiai; K Hayashi; M Nagao; T Sugimura
Journal:  Nucleic Acids Res       Date:  1987-06-25       Impact factor: 16.971

2.  Ribonucleic acid isolated by cesium chloride centrifugation.

Authors:  V Glisin; R Crkvenjakov; C Byus
Journal:  Biochemistry       Date:  1974-06-04       Impact factor: 3.162

3.  Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate.

Authors:  J P Chamberlain
Journal:  Anal Biochem       Date:  1979-09-15       Impact factor: 3.365

4.  Primary structure of v-raf: relatedness to the src family of oncogenes.

Authors:  G E Mark; U R Rapp
Journal:  Science       Date:  1984-04-20       Impact factor: 47.728

5.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

6.  Nucleotide sequence of avian retroviral oncogene v-mil: homologue of murine retroviral oncogene v-raf.

Authors:  P Sutrave; T I Bonner; U R Rapp; H W Jansen; T Patschinsky; K Bister
Journal:  Nature       Date:  1984 May 3-9       Impact factor: 49.962

7.  Serine- and threonine-specific protein kinase activities of purified gag-mil and gag-raf proteins.

Authors:  K Moelling; B Heimann; P Beimling; U R Rapp; T Sander
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

8.  Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.

Authors:  U R Rapp; M D Goldsborough; G E Mark; T I Bonner; J Groffen; F H Reynolds; J R Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  New mammalian transforming retrovirus: demonstration of a polyprotein gene product.

Authors:  U R Rapp; F H Reynolds; J R Stephenson
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

10.  Co-transfection of normal NIH/3T3 DNA and retroval LTR sequences: a novel strategy for the detection of potential c-onc genes.

Authors:  R Müller; D Müller
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  86 in total

1.  Raf-1 protein kinase is an integral component of the oncogenic signal cascade shared by epidermal growth factor and platelet-derived growth factor.

Authors:  S Kizaka-Kondoh; K Sato; K Tamura; H Nojima; H Okayama
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

2.  95-kilodalton B-Raf serine/threonine kinase: identification of the protein and its major autophosphorylation site.

Authors:  R M Stephens; G Sithanandam; T D Copeland; D R Kaplan; U R Rapp; D K Morrison
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

Review 3.  Molecular signal integration. Interplay between serine, threonine, and tyrosine phosphorylation.

Authors:  J Posada; J A Cooper
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

4.  Common mechanism of retrovirus activation and transduction of c-mil and c-Rmil in chicken neuroretina cells infected with Rous-associated virus type 1.

Authors:  M P Felder; A Eychène; J V Barnier; I Calogeraki; G Calothy; M Marx
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 5.  Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond.

Authors:  Matthew Holderfield; Marian M Deuker; Frank McCormick; Martin McMahon
Journal:  Nat Rev Cancer       Date:  2014-07       Impact factor: 60.716

6.  Extracellular signal-regulated kinase 7 (ERK7), a novel ERK with a C-terminal domain that regulates its activity, its cellular localization, and cell growth.

Authors:  M K Abe; W L Kuo; M B Hershenson; M R Rosner
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

7.  Functional role of GTPase-activating protein in cell transformation by pp60v-src.

Authors:  J E DeClue; W C Vass; M R Johnson; D W Stacey; D R Lowy
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

8.  Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.

Authors:  Hengyu Lu; Nicole Villafane; Turgut Dogruluk; Caitlin L Grzeskowiak; Kathleen Kong; Yiu Huen Tsang; Oksana Zagorodna; Angeliki Pantazi; Lixing Yang; Nicholas J Neill; Young Won Kim; Chad J Creighton; Roel G Verhaak; Gordon B Mills; Peter J Park; Raju Kucherlapati; Kenneth L Scott
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

9.  Analysis of AP-1 function in cellular transformation pathways.

Authors:  T Suzuki; M Murakami; N Onai; E Fukuda; Y Hashimoto; M H Sonobe; T Kameda; M Ichinose; K Miki; H Iba
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Raf-1 protein kinase is important for progesterone-induced Xenopus oocyte maturation and acts downstream of mos.

Authors:  A J Muslin; A M MacNicol; L T Williams
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.